Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer.
Vesci L, Milazzo FM, Anastasi AM, Petronzelli F, Chiapparino C, Carollo V, Roscilli G, Marra E, Luberto L, Aurisicchio L, Pacello ML, Spagnoli LG, De Santis R.
Vesci L, et al. Among authors: roscilli g.
Oncotarget. 2016 Jan 5;7(1):914-28. doi: 10.18632/oncotarget.6089.
Oncotarget. 2016.
PMID: 26575422
Free PMC article.